Basic and clinical research in oncology: is there background for a breakthrough?

Cover Page
  • Authors: Zhukov N.V.1,2,3, Rumyantsev S.A.1,2,3, Lukyanov S.A.1,4,5
  • Affiliations:
    1. N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow
    2. 1, Ostrovityanova st., Moscow, Russia,117997 Federal Research Center of Pediatric Hematology, Oncology and Immunology named after Dmitriy Rogachev, Ministry of Health of Russia, Moscow
    3. 1, Samory Mashela st., Moscow, Russia, 117198
    4. 1, Ostrovityanova st., Moscow, Russia,117997 M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow
    5. 16/10, Miklukho-Maklaya st., Moscow, GSP-7, Russia, 117997
  • Issue: Vol 9, No 4 (2014)
  • Pages: 54-66
  • Section: INVITATION TO DISCUSS
  • Published: 30.12.2014
  • URL: https://oncohematology.abvpress.ru/ongm/article/view/132
  • DOI: https://doi.org/10.17650/1818-8346-2014-9-4-54-66
  • ID: 132

Cite item

Full Text

Abstract

The appearance of anticancer drugs dramatically changed cancer treatment, allowing patients with a number of previously fatal diseases to achieve cure and prolong life in patients with incurable tumors. More than 100 anticancer drugs registered to date, many of which have been
developed in recent years using the latest advances in tumors molecular biology. At the same time the price of new anticancer drugs increases
much faster than efficacy of anticancer therapy. The situation is due largely to the fact that the current system of introduction of new anticancer drugs not performing initial tasks.

About the authors

N. V. Zhukov

N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow; 1, Ostrovityanova st., Moscow, Russia,117997

Federal Research Center of Pediatric Hematology, Oncology and Immunology named after Dmitriy Rogachev, Ministry of Health of Russia, Moscow; 1, Samory Mashela st., Moscow, Russia, 117198

Author for correspondence.
Email: zhukov.nikolay@rambler.ru
Russian Federation

S. A. Rumyantsev

N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow; 1, Ostrovityanova st., Moscow, Russia,117997

Federal Research Center of Pediatric Hematology, Oncology and Immunology named after Dmitriy Rogachev, Ministry of Health of Russia, Moscow; 1, Samory Mashela st., Moscow, Russia, 117198

Russian Federation

S. A. Lukyanov

N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow; 1, Ostrovityanova st., Moscow, Russia,117997

M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow; 16/10, Miklukho-Maklaya st., Moscow, GSP-7, Russia, 117997

Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2014



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-36928 от  21.07.2009.